Updated:
InferStat
Backtesting Made Easier | InferStat was a ML startup helping traders and portfolio managers to maximise the value of their research by statistical validation...
InferStat
Backtesting Made Easier | InferStat was a ML startup helping traders and portfolio managers to maximise the value of their research by statistical validation of trading rules through accessible online analytic tools. We ceased development in 2022.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Frequently asked questions
Is InferStat an active family office or investment firm?
No. The inferstat.com domain is currently listed for sale on the Atom marketplace. Altss research did not identify any operating entity, investment vehicle, or registered firm trading under the InferStat name. No principals, assets under management, or portfolio companies are associated with the name.
Where does the InferStat name come from?
The name is a portmanteau combining 'infer' (suggesting the drawing of conclusions) and 'stat' (short for statistics). The domain seller's listing copy targets data analytics companies, AI startups, or machine learning platforms. There is no known wealth origin or family-office lineage attached to the name.
Does InferStat have any known investment strategy or sector focus?
No. Because InferStat is only a domain listing, there is no investment strategy, asset-class preference, or sector focus to evaluate. Any future entity using the name would be defining its mandate from scratch.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: